News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Naveen Pemmaraju: Bromodomain and PLX51107 with Azacitidine in Patients with R/R Myeloid Malignancies
Naveen Pemmaraju/mdanderson.org
Mar 11, 2025, 08:03

Naveen Pemmaraju: Bromodomain and PLX51107 with Azacitidine in Patients with R/R Myeloid Malignancies

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, shared a paper he and his colleagues authored on X:

“Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies.”

Authors: Jayastu Senapati et al.

Naveen pemmaraju

cancer Courtney D. DiNardo Darla Miller Elias Jabbour Farhad Ravandi Gautam Borthakur Ghayas C. Issa Guillermo Garcia-Manero Jan Burger Jayastu Senapati Joseph D. Khoury Kapil N. Bhalla Koji Sasaki Lucia Masarova Marina Konopleva Nathaniel R. Wilson Naval Daver Naveen Pemmaraju Nicholas J. Short Nitin Jain OncoDaily Oncology Sherry Pierce Tapan Kadia Warren C. Fiskus Wei Qiao Yesid Alvarado
Special Coverage
Blog
Jun 19, 2025, 13:42
Raffaele Colombo: Preclinical development of DB-1419 published on Clinical Cancer Research AACR
Blog
Jun 19, 2025, 13:21
Mohamed Kharfan-Dabaja: Happy to Share Our Clinical Practice Recommendations in CLL on behalf of ASTCT
Oncolibrary
Jun 19, 2025, 13:13
New Paper Alert: KEYNOTE-689. Neoadjuvant and Adjuvant Pembrolizumab Improves Survival in Locally Advanced HNC
Blog
Jun 19, 2025, 13:04
Raul Cordoba Shared FOLL12 Trial on the Role of PET in Follicular Lymphoma
Oncolibrary
Jun 19, 2025, 13:01
Pancreatic Cancer Remission Rate: What Patients Should Know in 2025
Career
Jun 19, 2025, 12:40
Kristy Brown Received an $800,000 Grant Grom The V Foundation to Study How Obesity Impacts Cancer Research - KU Cancer Center
Science
Jun 19, 2025, 12:22
Justin Taylor: Happy to Share Our Latest Paper on XPO1 R749Q Mutations Online Ahead of Print in Cancer Research
Blog
Jun 19, 2025, 11:53
Yakup Ergün: Ivonescimab (PD-1 × VEGF) and Tarlatamab (DLL3 × CD3) are My Favorites Drugs For Lung Cancer - Even Better Ones Are Yet to Come
Blog
Jun 19, 2025, 10:28
Enrique Soto Perez de Celis on the Global Mission of CU Cancer Center's International Fellowship Program
Insight
Jun 19, 2025, 09:48
Nicholas Hornstein: Watching the Center of Gravity in Oncology Drug Development Move
Blog
Jun 19, 2025, 09:37
Majority of Americans Oppose Cuts to Medical Research Funding - AACR
Positive
Jun 19, 2025, 09:29
Margaret Foti: Great to See Riccardo Dalla-Favera at ICML 2025